Home page > OLD Wealth and Equity | WTO Cancun Ministerial, September 2003

Access to Medicines

More about the ongoing talks at WTO to increase access to essential medicines, especially in developing countries.

Please find all related articles below.

Added therapeutic value of medicines: EPHA/Wemos event in the European Parliament

On 15 July 2015 EPHA and Wemos hosted an event in the Members’ Salon at the European Parliament to highlight the issue of added therapeutic value (ATV) in medicines. Several studies carried out at EU member state level indicate that the majority of medicines authorised for use have little-to-no ATV in comparison with existing treatments. This means that public money is being spent on new, costly medicines which have limited ATV, whilst also using up resources which might otherwise be (...)

Evaluation of the Regulation on Tiered Pricing of Medicines

Supplying poor and developing countries with medicines at sustainable, reduced prices is one of the most important tools in the fight against major diseases, especially the “Big Three”, namely HIV, TB and malaria. After more than a decade since the Council Regulation (EC) 953/2003 came into force, to avoid trade diversion into the European Union of certain key medicines, stakeholders came together to discuss the overall impact of the Regulation at a workshop on 15 July 2015, (...)

Childhood vaccination: Neglected tool to counter measles outbreaks?

Over 22,000 people were infected with measles across the EU in 2014 and 2015, including one measles-related death. The only effective preventive measure against measles remains vaccination. The recent outbreaks suggest a growing number of susceptible people are not being vaccinated. The reasons for this are varied, including a growing number of parents who are reluctant to vaccinate their children and increasing barriers of access to vaccination. To avoid further such outbreaks, it is thus (...)

AMR’s multiple dimensions call for action on all fronts

The June Uppsala Health Summit (UHS), ‘A World Without Antibiotics’ expanded the discussion about antimicrobial resistance (AMR) at European and national level by examining this critical health threat from different angles. Among the key themes discussed were access to antibiotics and to improved diagnostics, the environmental dimension of AMR, collaborative research & innovation, and economic models allowing pharma companies to balance profits and investments for the public (...)

New report exposes link between global pharmaceutical production and anti-microbial resistance

A new report released on 11 June 2015 by global consumer watchdog SumOfUs.org provides a new angle to the debate about the major health threat of antimicrobial resistance (AMR): the improper disposal of pharmaceutical waste by polluting factories in China, and their links with some of the world’s biggest pharmaceutical companies. The report raises the urgent need for antibiotic stewardship to avoid a looming public health disaster. According to the report, polluting factories in (...)

[Press Release] New EU Migration Agenda falls short on health

Brussels, 18 May 2015 – - The European Commission released its European Agenda on Migration (1) on Wednesday 13 May. EPHA welcomes that action is finally being stepped up and more funding being made available, but warns that health requires further support. Health concerns – of migrants and of receiving countries’ populations - are notably absent in the agenda, which merely mentions the need to support ‘reception and capacity to provide healthcare to migrants in the (...)

Council conclusions on vaccinations as an effective tool in public health

On 1 December 2014, the Council of Health Ministers released its conclusions regarding vaccinations as an effective tool in public health. They invite national governments and the European Commission (EC) to increase information exchanges with the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) to focus on risk groups, and convey informed and clear messages on vaccination. The EPSCO conclusions adopted under the Italian Presidency - which (...)

Eurofound publishes study on access to healthcare in times of crisis

Eurofound - the European Foundation for the Improvement of Living and Working Conditions - published this week its report, ’Access to healthcare in times of crisis’. EPHA contributed to the report last year, conducting a case study of health system responses in Luxembourg. The report explores which population groups have experienced reduced access to healthcare as a result of the crisis. It presents examples of measures taken by governments and service providers to maintain (...)

[Press release] European Antibiotic Awareness Day: Fighting ‘superbugs’ to save lives

Brussels, 18 November – Today marks the 7th European Antibiotic Awareness Day (EAAD) (1) which promotes a more prudent use of antibiotics to tackle the growing challenge of multi-drug resistant ‘superbugs’ (2). Around 25,000 patients die every year in the European Union (EU) as a result of infections caused by antibiotic-resistant bacteria. Preventing the spread of antibiotic resistance will lead to significant health service savings since related costs amount to (...)

[Report] Patients suffering from medicines shortages in all European countries

A new report on medicines shortages experienced in European healthcare systems reveals that over 86% of hospital pharmacists are experiencing difficulties in sourcing medicines with 66% reporting this as a daily or weekly problem. The top affected areas are medicines to fight infection, cancer drugs and anesthetics. Brussels, 17 November 2014 - The report by the European Association of Hospital Pharmacists (EAHP), surveyed the experiences of over 600 hospital pharmacists in 36 European (...)